Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Echosens

News headline image
Echosens Presents Robust Research at 2022 AASLD Liver Meeting: Noninvasive FibroScan® Technology Recognized as Critical Component to Optimize Liver Health Management
From Echosens
Via Business Wire
News headline image
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
From Echosens
Via Business Wire
News headline image
Echosens Announces FibroScan Optimized Market Access Initiative
From Echosens
Via Business Wire
News headline image
Echosens Presents Symposium & Democenter at EASL International Liver Congress™ 2022: FibroScan® Solutions Bringing New Guidelines to Life, New FibroScan GO Demonstrations
From Echosens
Via Business Wire
News headline image
Echosens Partners with World Hepatitis Alliance on World Hepatitis Day, July 28, Urges Importance of Testing and Treatment
From Echosens
Via Business Wire
News headline image
American Association of Clinical Endocrinology New Clinical Practice Guidelines Recommend VCTE FibroScan® Technology by Echosens
From Echosens
Via Business Wire
News headline image
Echosens Supports American Minority Health Month in April, Highlights Need for Early Liver Disease Detection Among Hispanic Groups
From Echosens
Via Business Wire
News headline image
New Baveno VII Guidelines Further Validate FibroScan by Echosens for Management of Patients with Advanced Chronic Liver Disease
From Echosens
Via Business Wire
News headline image
Echosens Supports American Heart Month in February, Highlights Growing Prevalence and Relationship Between Liver Disease and Heart Health
From Echosens
Via Business Wire
News headline image
Innovative New Products and Technology Advancing Worldwide Liver Disease Management Highlight Echosens 20th Anniversary
From Echosens
Via Business Wire
News headline image
Early Identification of Fatty Liver Using Echosens FibroScan Potentially Gives Payers Five-Year Gross Savings of $10+ Million, Confirmed by Independent Study
From Echosens
Via Business Wire
News headline image
World Diabetes Day and American Diabetes Month: Echosens Highlights Link Between Diabetes and Liver Disease, Urges Non-Invasive Detection and Monitoring
From Echosens
Via Business Wire
News headline image
Echosens Presents Research at 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan Mitigates Risk of Patients Developing Fibrosis/Cirrhosis
From Echosens
Via Business Wire
News headline image
Echosens Underscores Impact of Obesity in Nonalcoholic Fatty Liver Disease & Metabolic Syndrome, Emphasizes Role of FibroScan to Monitor Liver Stiffness and Fat at Point-of-Care
From Echosens
Via Business Wire
News headline image
Echosens Highlights New EASL Clinical Practice Guidelines: Unprecedented Recommendation for Non-Invasive FibroScan and Care Management
From Echosens
Via Business Wire
News headline image
Echosens Partners with Veteran-Owned Fidelis: Announces Addition of FibroScan to US Defense Logistics Agency’s Medical Equipment ECAT
From Echosens
Via Business Wire
News headline image
Leading Liver Disease Researchers Present at EASL International Liver Congress™ 2021, Demonstrate Prognostic Value of Echosens’ FibroScan-based Agile Scores for Patients with Liver Disease
From Echosens
Via Business Wire
News headline image
Echosens Launches New FibroScan-Based Scores Agile 3+ & Agile 4: Identifies Advanced Fibrosis and Cirrhosis, Predicts Clinical Outcomes, Improves Patient Management
From Echosens
Via Business Wire
News headline image
Echosens Sponsors First Annual Liver Health Matters Month in June, Celebrates 20 Years of Battling Liver Disease Epidemic, Preventing Disease Progression
From Echosens
Via Business Wire
News headline image
Echosens Launches SmartExam®: FibroScan® Software Upgrade Unlocks the True Power of Company’s Innovative and Differentiated Technology
From Echosens
Via Business Wire
News headline image
Echosens Announces Peer-Review Publication of Actuarial Study in American Journal of Managed Care: Positive Return on Investment of VCTE/CAP FibroScan Technology to Detect and Monitor Liver Health
From Echosens
Via Business Wire
News headline image
Echosens Supports 2021 April National Alcohol Awareness Month: Urges More Americans to Learn About Alcohol Addiction and Rise in Fatty Liver Disease
From Echosens
Via Business Wire
News headline image
Echosens Presents at AMCP 2021 Virtual Event: “Modeling the Return on Investment of VCTE for Fatty Liver Disease (FLD) in a General Population Incorporating Device Costs”
From Echosens
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.